| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/09/2009 | US20090093020 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
| 04/09/2009 | US20090093019 Production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 04/09/2009 | US20090093018 Method of producing heterodimer derivative of protein phosphatase type 2a enzyme |
| 04/09/2009 | US20090093017 suitable for use in efficiently expressing a truncated form of protein A polypeptides in non-pathogenic bacteria, especially E. coli, without being significantly degraded within the bacteria; purifying a protein A polypeptide that includes an Fc region of an IgG immunoglobulin |
| 04/09/2009 | US20090093016 Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides |
| 04/09/2009 | US20090093015 Beta-cryptoxanthin production using a novel lycopene beta-monocyclase gene |
| 04/09/2009 | US20090093000 Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease |
| 04/09/2009 | US20090092992 Novel human dickkopf-related protein and nucleic molecules and uses therefor |
| 04/09/2009 | US20090092638 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 04/09/2009 | US20090092634 Chicken Virus Vaccine and Diagnostic |
| 04/09/2009 | US20090092627 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2009 | US20090092623 Promoter |
| 04/09/2009 | US20090092613 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 04/09/2009 | US20090092612 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 04/09/2009 | US20090092607 Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 04/09/2009 | US20090092606 Antibacterial treatments |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092597 Mammalian cell surface antigens; related reagents |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092582 Compositions and methods for modifying properties of biologically active polypeptides |
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092579 Novel method for down-regulation of amyloid |
| 04/09/2009 | US20090092578 Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereof |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | US20090092546 Carrier molecules |
| 04/09/2009 | DE19543553B4 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 04/09/2009 | CA2734139A1 Antibody therapy for use in the digestive tract |
| 04/09/2009 | CA2700860A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/08/2009 | EP2045329A1 Flagellin mutant vaccine |
| 04/08/2009 | EP2045328A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same |
| 04/08/2009 | EP2045324A1 Method for production of n36-binding peptide |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2045261A1 Chlamydia pneumoniae antigenic polypeptides |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044224A2 Chimeric virus-like particles |
| 04/08/2009 | EP2044119A1 Cancerous disease modifying antibodies |
| 04/08/2009 | EP1559318B1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 04/08/2009 | EP1476468B9 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 04/08/2009 | EP1244692B1 Compositions and methods for detecting stress-inducible proteins |
| 04/08/2009 | EP1151143B1 Selection of proteins using rna-protein fusions |
| 04/08/2009 | EP1007569B1 Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitope |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | CN101405401A Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 04/08/2009 | CN101405393A The use of protein S fusion for protein solubilization |
| 04/08/2009 | CN101405389A Novel protein expression system |
| 04/08/2009 | CN101405384A Cell culture substrate |
| 04/08/2009 | CN101402986A Method for producing collagen, glutin or collagen by degreasing and deliming of fish scale |
| 04/08/2009 | CN101402968A Expression method of human anti-zymoplasm III, special-purpose expression vector and engineering bacterium thereof |
| 04/08/2009 | CN101402956A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402954A Method for expressing recombinant pig lactoferrin N leaf with pichia thermophilic methanol yeast |
| 04/08/2009 | CN101402921A Method for producing gamma-glutamylcycteine |
| 04/08/2009 | CN101401821A Bee pollen peptide slice and preparation method thereof |
| 04/08/2009 | CN100475972C Preparation of shrimp peptide powder |
| 04/08/2009 | CN100475963C Chicken infectivity bursa of Fabricius virus VP2 cDNA, its expression vector, expressed recombinant protein and application thereof |
| 04/08/2009 | CN100475960C Method for the recombination of genetic elements |
| 04/08/2009 | CN100475848C Anti-TRAIL-R antibodies |
| 04/08/2009 | CN100475845C Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 04/08/2009 | CN100475842C Molecular structure of RHD negative genes locus |
| 04/08/2009 | CN100475833C Process for extracting N6-(2-ethoxyl) adenosine from Paecilomyces Cicadae Samson culture |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514545 An isolated nucleotide sequence encoding a regulatory fusion protein consisting of modified ligand-binding domain of a human estrogen receptor and a transcription blocking domain comprising a mutated restriction enzyme capable of binding but not cleaving DNA |
| 04/07/2009 | US7514542 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 04/07/2009 | US7514538 Compositions and methods for the diagnosis and treatment of tumor |
| 04/07/2009 | US7514536 interleukins produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; polypeptide has anti-hepatitis C activity |
| 04/07/2009 | US7514533 polypeptides and the nucleotide sequence from the encoding gene, used in the diagnosis, prevention, and treatment of diseases |
| 04/07/2009 | US7514403 Process for the stabilization of proteins in an aqueous solution comprising cysteine in a concentration between 150 and 220mM |
| 04/07/2009 | US7514257 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation |
| 04/07/2009 | US7514243 Process for producing dipeptides |
| 04/07/2009 | US7514240 a crystal complex of an epidermal growth factor (EGF) and an epidermal growth factor receptor (EGFR), used for screening and for designing the substance that regulate EGFR activity |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514238 Growth factor homolog zvegf4 |
| 04/07/2009 | US7514237 mammalian cells comprising recombinant expression cassette encoding a protein of interest and an X-box binding protein or variant that binds the endogenous endoplasmic reticulum stress response element or unfolded protein response element of the cell to enhance protein folding or processing capacity |
| 04/07/2009 | US7514227 contacting an antibodies or fragments which binds to human mitochondrial adenylate kinase isozymes with biological sample from a subject and normal control subject, then detecting the immune complex formed as detection markers for diagnosing myocardial infarction |
| 04/07/2009 | US7514222 polypeptides or proteins consisting of a four helix bundle formed of two dimerized helix-loop-helix motifs |
| 04/07/2009 | US7514215 Sulfotransferase SULT2A1 sequence variants |
| 04/07/2009 | US7514110 Talaromyces xylanases |
| 04/07/2009 | US7514083 Protein allergens of the species cynodon dactylon |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2389943C Human antibodies that bind human tnf.alpha. |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2294575C Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 04/07/2009 | CA2268386C High molecular weight trichoderma cellulase |
| 04/07/2009 | CA2264488C A method for generating birnavirus from synthetic rna transcripts |
| 04/07/2009 | CA2237157C Cyclopeptolide inhibitors of adhesion molecules |
| 04/07/2009 | CA2220447C Novel fusion protein recovery and purification methods |
| 04/07/2009 | CA2206343C Reagents and processes for targeting mutant epidermal growth factor receptors |
| 04/07/2009 | CA2205914C Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2151883C Synthetic tropoelastin |
| 04/07/2009 | CA2127262C Somatostatin receptors |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042917A1 Methods and compositions for antibody production |
| 04/02/2009 | WO2009041858A1 METHOD FOR PRODUCING HUMAN PROINSULIN RECOMBINANT c-PEPTIDE |
| 04/02/2009 | WO2009041734A1 Agonistic antibody against human thrombopoietin receptor |
| 04/02/2009 | WO2009041643A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | WO2009041613A1 Modified antibody constant region |
| 04/02/2009 | WO2009041062A1 Anti-glypican-3 antibody having improved kinetics in plasma |